Pulmonary colonization of Candida albicans drives breast cancer lung metastasis via candidalysin
Authors: Z. Ma, L. Chen, Y. Fang, F. Gao, L. Liu, J. Wu, H. Chen, Y. Tian, Y. Zhang, X. Yang, Y. Wang, M. Ren, Y. Liu, L. Zhu, C. Chen, M. Guan, P. Tang, L. Wang, C. Li
Abstract
The intratumoral mycobiome is emerging as a key modulator of cancer progression, with specific fungal taxa as potential biomarkers. However, whether and how mycobiomes colonizing distant organs contribute to tumor evolution remains largely unexplored. Here, we identify selective enrichment of Candida albicans in breast cancer lung metastases. Mechanistically, the fungal virulence factor candidalysin activates pulmonary mast cells, which release chemotactic mediators that expand immunosuppressive populations and suppress cytotoxic lymphocyte activity, remodeling the lung into a metastasis-permissive microenvironment. Analysis of clinical isolates and isogenic mutants further demonstrates that candidalysin secretion levels dictate metastasis-promoting potential. Informed by these findings, we developed a combination regimen that concurrently eliminates fungal colonization, stabilizes mast cells, and reverses the immunosuppressive microenvironment, thereby significantly curtailing metastatic progression. Collectively, our study establishes pulmonary C. albicans colonization as a driver of breast cancer lung metastasis and provides a mechanistic framework for targeting mycobiome-host interactions in metastatic disease.
The papers around it, by date and closeness
Higher is closer to this paper; left is older. Lines join papers close to each other: groups of lines are sub-topics. Select a point to see why it is there. Back to the summary of this paper
Papers around this one
Ranked by how close their title and abstract are to this paper’s. Select some to read them together.
Closest papers
-
Complex Interrelationships Between Tumors, the Mycobiota, and Systemic ChemotherapyO. Zolotukhin, Y. Konechnyi, V. Havryliak et al. · 2026 · Microorganisms · Not summarized yet
This review summarizes how tumor-associated fungi influence cancer development and systemic anticancer therapy, including immune modulation and tumor-microenvironment remodeling.
Abstract
The fungal microbiome is an increasingly recognized component of the tumor microenvironment, yet its interactions with cancer development and systemic anticancer therapy remain poorly characterized. This review summarizes current evidence on the role of fungi in tumors and their interactions with systemic chemotherapy and antifungal therapy. We discuss potential mechanisms by which the mycobiota may contribute to oncogenesis through immune modulation, remodeling of the tumor microenvironment, chronic inflammation, angiogenesis, and other tumor-supportive processes. We further examine evidence that several anticancer agents, including doxorubicin, cisplatin, and bleomycin, exhibit antifungal …
-
Gut mycobiome dysbiosis in digestive system cancers: immune remodeling and translational implicationsLin Ma, Zhen Wang, Jie Mao · 2026 · Frontiers in Cellular and Infection Microbiology · Not summarized yet
This review surveys fungal dysbiosis and immune remodeling in digestive-system cancers, including Candida signals in gastric cancer and causal fungal mechanisms in mouse models.
Abstract
Fungal dysbiosis has been reported in colorectal cancer (CRC), gastric cancer (GC), and pancreatic ductal adenocarcinoma (PDAC), but evidence strength differs substantially by tumor type and model system. Human CRC studies provide the broadest ecological evidence, including altered fungal community structure and fungal-bacterial networks. Human GC evidence is mainly cross-sectional and identifies Candida albicans as a candidate tissue-associated signal rather than a proven driver. In PDAC, human tissue studies report fungal signals, whereas causal support for Malassezia–mannose-binding lectin (MBL)–complement and fungal IL-33/type 2 immunity derives principally from mouse perturbation models…
-
The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentialsYu-Jie Huang, Jia Ma, J. Bi et al. · 2026 · Frontiers in Immunology · Not summarized yet
This review examines how CCL2–CCR2 signaling recruits immunosuppressive cells and helps create metastatic niches, rather than focusing on fungal colonization.
Abstract
Lung cancer remains the leading cause of cancer-related mortality worldwide, with metastasis, therapeutic resistance, and an immunosuppressive TME representing major barriers to successful treatment. Among the chemokine signaling networks implicated in these processes, the CCL2–CCR2 axis has emerged as an important regulator of tumor progression. By orchestrating the recruitment of monocytes, tumor-associated macrophages, myeloid-derived suppressor cells, and other stromal components, this pathway can establish an immune-permissive niche that supports angiogenesis, epithelial–mesenchymal transition, extracellular-matrix remodeling, metastatic dissemination, and resistance to chemotherapy, ta…
-
Intratumoral Microbiome–Tumor Microenvironment Crosstalk in Breast Cancer AggressivenessO. Mushii, Ye Lukianova, V. Bazas · 2026 · The Breast Journal · Not summarized yet
This review discusses how intratumoral microorganisms may shape breast cancer progression through inflammation, hormone metabolism, and other mechanisms.
Abstract
Breast cancer (BC) remains the most common malignancy among women worldwide, with incidence and mortality rates continuing to rise. Alongside tumor heterogeneity and diverse clinical outcomes, increasing attention has been directed toward the role of the intratumoral microbiome as a regulator of breast tumorigenesis. Recent evidence demonstrates that breast tissue harbors one of the most diverse microbial communities compared with other cancer types, with marked differences between normobiota and malignant tissue. Intratumoral microorganisms are potentially associated with BC progression through multiple mechanisms, including modulation of inflammation, steroid hormone metabolism, and extrac…
-
Oral Fungal Infection Impacts Epithelial Innate Immunity to Promote Local and Distal Squamous Cell Carcinoma ProgressionXin Li, A. K. Singh, Na-Young Song et al. · 2026 · Cancer Research · cited 1 time · Not summarized yet
This study links oral fungal infection to local and distant squamous cell carcinoma progression through altered epithelial innate immunity.
Abstract
Fungi have been detected within human tumors and shown to support tumor progression. A better understanding of how intratumoral fungi evade innate immunity, remodel the tumor microenvironment (TME), and promote tumorigenesis may provide insights into cancer pathogenesis and therapeutic strategies. Here, we showed that aggressive human head and neck squamous cell carcinomas (HNSCCs) harbor an elevated fungal burden, including the environmental fungus Cladosporium cladosporioides, and are infiltrated by IL1B-high neutrophils with impaired reactive oxygen species (ROS) production and phagocytosis, as well as IL1B-high macrophages. In a mouse model in which Ikka ablation drives tumorigenesis thr…
-
Candida albicans in oral squamous cell carcinoma: a review of mechanistic pathways and clinical translational strategiesPei-Ning Zheng, Qing-Qi Xie, Kenneth K. Y. Cheng et al. · 2026 · Frontiers in Cellular and Infection Microbiology · Not summarized yet
This review evaluates evidence for Candida albicans in oral squamous cell carcinoma, distinguishing association from causal and translational evidence.
Abstract
Oral squamous cell carcinoma (OSCC) develops within a complex mucosal ecosystem in which microbial dysbiosis, epithelial injury, inflammation, and immune remodeling interact with established carcinogenic exposures. Although Candida albicans has repeatedly been associated with OSCC and oral potentially malignant disorders (OPMDs), its causal and translational significance remains uncertain. This review critically evaluates clinical, microbiological, mechanistic, and translational evidence, with particular attention to the distinction between association, biological plausibility, and causal inference. Current evidence is more consistent with context-dependent tumor-promoting activity than with…
-
Candida albicans promotes self-adhesion and tumor cell progression of colorectal cancer cellsJanet F. Staab, Olivia K. A. Paulin, J. Naglik et al. · 2026 · bioRxiv · preprint, not peer reviewed · Not summarized yet
This study examines Candida albicans effects on colorectal cancer cells, including self-adhesion and tumor-cell progression.
-
The intratumoral microbiome in breast cancer: an actionable component of the tumor immune microenvironmentChiara Cossu, Manuel Adamo, Antonino Di Lorenzo et al. · 2026 · Frontiers in Immunology · Not summarized yet
This review surveys breast tumor microbiota and their potential effects on immune modulation, metastatic dissemination, and treatment response.
Abstract
Breast cancer remains one of the leading causes of cancer-related deaths in women. The discovery of a breast tumor microbiota has deeply changed our understanding of the breast tumor microenvironment, identifying microorganisms as active players in tumor progression. Increasing evidence suggests that intratumoral bacteria may influence multiple hallmarks of breast cancer, including chronic inflammation, immune modulation, metabolic reprogramming, epithelial plasticity, metastatic dissemination, and therapeutic response. Distinct microbial communities have been associated with specific breast cancer subtypes and clinical outcomes, and some mechanistic studies have demonstrated that individual…
Go further
How are these papers found?
We compare the title and abstract of this paper with those of every paper summarized on this site, and with the papers Semantic Scholar recommends, those it cites and those citing it (for a much-cited paper, its most recent citations and, from OpenAlex, the most cited ones). Among the prior work and the follow-ups, the papers that use each other in depth, a method it uses and the much-cited follow-ups come a little higher. The levels (very close, close, related) come from the similarity of the texts, not from a judgment of quality; * marks a paper without an abstract, compared by its title. The sentence under a paper is written by an AI from the two abstracts: check it in the papers. A paper marked not relevant by three readers leaves the list.
Updated on 2 November 2026.